Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
BetaShares - Global Healthcare Currency Hedged ETF

DRUG.AX Technical Analysis Summary (ASX)

Analyze DRUG.AX on the ASX with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

DRUG.AX●ASX
Financial ServicesAsset Management - Global
$8.91
$0.06(0.68%)
Australian Market opens in 4h 43m

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

DRUG.AX Technical Analysis Summary (ASX)

BetaShares - Global Healthcare Currency Hedged ETF (ASX: DRUG.AX) stock currently shows a neutral trend on the ASX, supported by momentum and balanced buying pressure.

Overall Sentiment:Neutral
Momentum:Neutral to Bearish (RSI: 48.95)
Trend Strength:Weak (ADX: 15.32)
Volatility:Low (ATR: 0.09)
Support/Resistance:$8.62 – $9.29 (Bollinger Bands)

Technical conditions suggest BetaShares - Global Healthcare Currency Hedged ETF on the ASX is awaiting a decisive move. Technical conditions suggest BetaShares - Global Healthcare Currency Hedged ETF is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 48.95

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 32.65

Bearish
Momentum remains weak below midpoint.

Williams %R: -61.22

Bearish
Sellers maintain momentum below neutral.

Rate of Change (ROC): -1.44

Bearish
Selling pressure outweighs buying.

Takeaway:BetaShares - Global Healthcare Currency Hedged ETF shows weakening momentum, with sellers gaining the edge.

Trend & Volatility

MACD: -0.03

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 15.32

Weak
Weak trend, market trading sideways.

ATR (14): 0.09

Low
Low volatility, stable price action.

CCI (14): -13.44

Neutral
Neutral, no strong directional signal.

Takeaway:BetaShares - Global Healthcare Currency Hedged ETF shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$9.29
Middle Band (SMA 20)
$8.95
Lower Band
$8.62
Current Position
Within Bands

Takeaway:BetaShares - Global Healthcare Currency Hedged ETF trades closer to support, showing weaker momentum within bands.

Keltner Channels
Upper Channel
$9.06
Middle Line (EMA 20)
$8.88
Lower Channel
$8.71
Squeeze Status
No Squeeze

Takeaway:BetaShares - Global Healthcare Currency Hedged ETF trades above the trend line, showing healthy momentum within the channel.

Volume & Money Flow Analysis
On-Balance Volume-3.68M
Money Flow Index46.98Neutral, balanced money flows with no clear signal.
Relative Vigor Index47.88Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:DRUG.AX shows neutral money flow, with no clear directional pressure.

Technical Trading Signals Summary
Based on the current technical analysis of BetaShares - Global Healthcare Currency Hedged ETF (ASX: DRUG.AX), here are the key trading signals and recommendations:

Bullish Signals

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:BetaShares - Global Healthcare Currency Hedged ETF shows a Neutral outlook — indicators suggest balanced momentum with no clear directional trend.

(ASX: DRUG.AX) Technical Analysis FAQ